dual PPAR-gamma/delta modulators (Seoul National University/Chonnam National University/Future Medicine/Hanyang University)

N/A

Report date: 2025/01/26 18:33:55
NME

Base Information

Drug Namedual PPAR-gamma/delta modulators (Seoul National University/Chonnam National University/Future Medicine/Hanyang University)
Drug Alias NamePPAR-Gamma Partial Agonist/PPAR-Delta Antagonist (Seoul National University/Hanyang University/Future Medicine/Chonnam National University)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPeroxisome proliferator-activated receptor γ partial agonistsPeroxisome proliferator-activated receptor delta inhibitors
TargetsPeroxisome proliferator-activated receptor γPeroxisome proliferator-activated receptor delta
Therapy Area/IndicationsDiabetes Mellitus, Type 2Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesSeoul National University
China Registration ClassN/A

Develop Information

Active CompaniesChonnam National UniversityFuture Medicine Co LtdHanyang University +[4] 
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A